Department of Temporomandibular Joint and Occlusion, School/Hospital of Stomatology, Lanzhou University, Dong Gang Xi Road 199#, Lanzhou, 730000, People's Republic of China.
Department of Orthodontics, Xiangya Hospital and School of Stomatology, Central South University, Changsha, 410078, People's Republic of China.
Lasers Med Sci. 2021 Jul;36(5):1101-1108. doi: 10.1007/s10103-020-03197-7. Epub 2020 Nov 23.
To compare the effects of different energy density LLLT on TMD patients' pain reduction.
Reviewers searched RCTs published in Embase, PubMed and The Cochrane Library before 1 April 2020. Reviewers included parallelRCTs that compared the effects of LLLT with placebo or different energy density LLLT for TMD patients' pain reduction. Reviewers did network meta-analysis and evaluated the quality of evidence using the GRADE process.
From 352 studies, reviewers included 16 RCTs. Immediately after treatment, the d1 laser therapy (energy density ranging from 0 to 10 J/cm) ranked first. The d1 laser therapy showed more pain reduction than placebo ( MD = 2.49, 95% CI ranging from 1.28 to 3.71). The quality of "d1 vs p" comparison was assessed as "moderate" quality. A month after treatment, the d1 laser therapy also performed better than placebo (MD = 1.69, 95%CI = [-0.78, 4.16]). The quality of secondary outcome was assessed as "low" quality.
For clinical application, d1 laser therapy (energy density ranging from 0 to 10 J/cm) is recommended for short-term pain management of TMD patients (moderate quality evidence). A month after treatment, the d1 laser therapy also performed better than placebo and other laser groups but the result didn't reach the point of statistical significance (low quality evidence).
PROSPERO-CRD42018118313.
比较不同能量密度低水平激光疗法(LLLT)对颞下颌关节紊乱病(TMD)患者疼痛缓解的效果。
检索员在 2020 年 4 月 1 日前在 Embase、PubMed 和 The Cochrane Library 中检索了发表的 RCT。检索员纳入了比较 LLLT 与安慰剂或不同能量密度 LLLT 对 TMD 患者疼痛缓解效果的平行 RCT。检索员进行网络荟萃分析,并使用 GRADE 过程评估证据质量。
从 352 项研究中,检索员纳入了 16 项 RCT。治疗后即刻,d1 激光治疗(能量密度 0-10 J/cm)排名第一。d1 激光治疗较安慰剂显示出更大的疼痛缓解(MD=2.49,95%CI 为 1.28-3.71)。“d1 与 p”比较的质量被评估为“中等”质量。治疗后 1 个月,d1 激光治疗也优于安慰剂(MD=1.69,95%CI 为[-0.78,4.16])。次要结局的质量被评估为“低”质量。
对于临床应用,推荐 d1 激光治疗(能量密度 0-10 J/cm)用于 TMD 患者的短期疼痛管理(中等质量证据)。治疗后 1 个月,d1 激光治疗也优于安慰剂和其他激光组,但结果未达到统计学意义(低质量证据)。
PROSPERO-CRD42018118313。